Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chitra R Natalie"'
Autor:
Amy S. Paller, Carsten Flohr, Lawrence F. Eichenfield, Alan D. Irvine, Jamie Weisman, Jennifer Soung, Ana Pinto Correia, Chitra R. Natalie, Claudia Rodriguez Capriles, Evangeline Pierce, Sarah Reifeis, Renata Gontijo Lima, Clara Armengol Tubau, Vivian Laquer, Stephan Weidinger
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 7, Pp 1517-1534 (2023)
Abstract Introduction Atopic dermatitis (AD) is a chronic inflammatory skin disorder with limited treatment options for adolescents with moderate-to-severe disease. Lebrikizumab, a monoclonal antibody targeting interleukin (IL)-13, demonstrated clini
Externí odkaz:
https://doaj.org/article/f1994888427840c4b87a98813eff0651
Autor:
Andrew Blauvelt, Jacob P Thyssen, Emma Guttman-Yassky, Thomas Bieber, Esther Serra-Baldrich, Eric Simpson, David Rosmarin, Hany Elmaraghy, Eric Meskimen, Chitra R Natalie, Zhuqing Liu, Chenjia Xu, Evangeline Pierce, MaryAnn Morgan-Cox, Esther Garcia Gil, Jonathan I Silverberg
Publikováno v:
British Journal of Dermatology. 188:740-748
Background Lebrikizumab is a novel, high-affinity monoclonal antibody that selectively binds to interleukin (IL)-13. Objectives To evaluate the efficacy and safety of lebrikizumab monotherapy in adolescent and adult patients with moderate-to-severe a
Autor:
Melinda Gooderham, Vivian Y Shi, Andreas Wollenberg, Jacob P Thyssen, Tiago Torres, Esther Garcia Gil, Laia Bardolet, Chitra R Natalie, Amber R Atwater, Fangyi Zhao, Andrew Blauvelt
Publikováno v:
British Journal of Dermatology. 188
Lebrikizumab is an injectable, IgG4 monoclonal antibody that selectively binds to interleukin-13 with high affinity. Injection-site reactions (ISRs) are localized adverse events in the immediate site of administration of a drug and are common with in
Autor:
Kari C. Nadeau, Anthony R. Ricci, Rosalba E. Puente, Karin S. Coyne, Acklema Mohammad, Patricia H. Stewart, Peggy Rubio O’Connor, Kevin R. Murphy, Nathan James Lesch, Pulin P. Patel, Russell Settipane, Reneé Stadtler, David C. Mares, Jeffrey Rehm, James M. Eudicone, Rabinder Sidhu, Weily Soong, Christine Czajkowski, Allison Ramsey, Amanda L. Michaud, Lori A. Bowers, Xavier Soler, Theodore E. Kelbel, Andrew M. Smith, S. Shahzad Mustafa, Ewa Rakowski, Martha V. White, Raji M. Ayinla, Robert A. Wise, Bruce M. Schnapf, Maxcie M. Sikora, Brett V. Kettelhut, Sherif Al-Farra, Jason M. Bellak, Tabarak Qureshi, Vipin Jain, Adam T. Cherry, Danuel Hamlin, Jennifer Trevor, Taiwen Chen, Lindsay D. Humes, Joseph Dominic Fisher, Neal Jain, Sonia N. Bains, James E. Pearl, Florence Ida Hsu, Patricia L. Luthin, Ziad R. Mattar, Chitra R. Natalie, Edward Schuman, Kartik Shenoy, Susan Estrella-Eades, Mitchell Smith, Gary N. Gross, Ileen Gilbert, Cara Kraft, Francis J. Averill, William McCann, Bradley E. Chipps, Howard J. Lee, J. Paul Cook, Leslie A. Stefanowicz, B. Steele Rolston, Jonathan R. Romeo, R. Sharon Chinthrajah, Sami Abdul Jawad, Brian Stone, Eugene R. Bleecker, Daisy Arce, David G. Hill, John G. Southard, Justin Greiwe, Jonathan Ilowite, Christine Anderson, Joann Blessing-Moore, Jorge Manuel Mercado, Amy Palmer, James P. Krainson, Jill Hanson, Sarah Villegas, Sandra G. Adams, Ellen R. Sher, Karen L. Gregory, Thomas P. Miller, Hassan Nasir, David Pham, Neil Parikh, Bryan Krajicek, John Gedell, Gale Harding, Devi K. Jhaveri, Steven L. Wise, Salim Surani, Maeve Edel O’Connor, Alan Gaines, Franco Barsanti, Andrew S. Kim, Matthew C. Wilson, Andrew A. White, David A. Beuther, Javier Perez-Fernandez, Igor Barjaktarevic, Melvin Lee Morganroth, Matthew Hegewald, Shyamsunder Subramanian, H. Gandhi, Jodi H. Biller, G. Gilbert Head, Da-Wei Liao, Nicholas L. Hartog, Carly Hopkins, Brian D. Modena, Richard A. Wachs, Rory L. Duplantier, Edward Kerwin, Robert S. Zeiger, Laren D. Tan, Aaron K. Kobernick, Randall Brown, Susan M. Smith, Jon Eric Chancellor, Alan Fein, Peter Schochet, Geoffrey Chupp, Mario F. Perez, Ronald C. Balkissoon, Derek K. Johnson, Nabeel Farooqui, Steven G. Kelsen, Diego J. Maselli, Jessica Freyer Most, Pinkus Goldberg, Deborah Simmons
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 8:2263-2274.e5
Background Asthma exacerbation risk increases with worsening asthma control. Prevailing numerical control tools evaluate only current symptom impairment despite the importance of also assessing risk based on exacerbation history. An easy-to-use quest